steelerfan7 4 Part DD EPGL DD : part 1 EPGL 20

steelerfan7 4 Part DD

EPGL DD : part 1

EPGL 2010 JOHNSTOWN, PA May 17, 2010 – EP Global Communications, Inc . (EPGL), (the Company) , (EPGL.PK), (www.eparent.com), the parent company of Exceptional Parent (EP) magazine , is proud to report that plans for the opening of the new EP Health Sciences Division and 2010 timetable for the release of the Nutraceuticals Resource Guide, along with the new treatment therapy utilizing the Muscle Pain Detection Device (MPDD) by Dr. Norman

http://www.eparent.com/home_ep_news/EP_Expand...rinter.asp

NIR
The NIR Group was taking shares from EPGL, for financing, and short selling! Finally the sec put an end to NIR and elected Price water house to clean house for NIR clients! Here's a clip! NIR Group portfolio companies (penny stocks who issued convertible notes to NIR in exchange for a loan) the DOJ has issued subpoenas last month for their transfer agents. Sources familar with the situation say this move means the DOJ is looking at all the penny stock sold and issued to NIR Group for at least the last five years. While the SEC sued NIR Group and Ribotsky for investor fraud we didn’t see any charges for illegal moves in the PIPE deals NIR Group invested in. Naked short selling is one complaint NIR Group portfolio companies have listed in their civil suits against the hedge fund over the years but Ribotsky always settles these suits before it’s time for him to testify during the discovery process.

Link: http://www.teribuhl.com/tag/nir-group-liquidator/

EPGL DD: part 2

The link between Dr. Marcus, Stevens Institute!

Dr. Norman Marcus and The Stevens Institute! clip: Working with the Stevens Institute of Technology’s Biomedical Engineering Department, Dr. Norman Marcus has invented a revolutionary device, Muscle Pain Detection Device (MPDD), that can electrically identify a muscle that is causing pain in any area of the body. This discovery will change the way doctors examine patients in the future!

Link: http://www.nmpi.com/f-a-q/muscle-pain-detection-device

Clip: SPOC is a Technogenesis™ company formed at Stevens Institute of Technology via the office of Institute Technology Initiatives. SPOC has developed a clinical and technological platform that promises to greatly increase the accuracy with which muscle pain is diagnosed and drive down health care costs associated with chronic pain. SPOC has set forth to capitalize on an opportunity to work with Dr. Norman Marcus, a leading pain management physician, on developing a medical device to facilitate his revolutionary method for pain diagnosis.

Link: http://www.stevens.edu/entrepreneurship/ventures/SPOC.html


EPGL DD : part 3

EPGL Today!

EP Global Communications, Inc. Reaches Agreement With Major Debt Holders to Restructure and Become Medical Device Manufacture... Date : 03/28/2012 @ 8:08AM

Link: http://ih.advfn.com/p.php? pid=nmona&article=51800559

The company EPGL will buy!

SPOC is a Technogenesis™ company formed at Stevens Institute of Technology via the office of Institute Technology Initiatives! They have FDA approval and patent!)

http://www.stevens.edu/entrepreneurship/ventures/SPOC.html

The Market for the MPDD!

Market for the mpdd!!!

SPOC does not compete with current methods of pain diagnosis. Instead, SPOC will enhance current methods of diagnosis and treatment. Thus, helping realize the full value of current diagnostic tools such as MRI, CT scan, X-ray standard physical examination.

SPOC will compliment the pharmaceutical industry by helping doctors to properly correlate the prescription of pain killers to the correct source of pain. This may help patients achieve lasting relief by pharmaceutics alone, rather than more drastic procedures such as surgery.

EPGL DD part 4

more mpdd market info:

The primary market will be pain management physicians and will then expand to sports medicine, physical therapists, and fitness centers. There will be a parallel expansion with general practitioners at a different saturation rate due to disparity in the need for pain diagnosis in routine checkups vs. the greater need by pain and physical therapists. Ideally the SPOC device will be as common as the stethoscope in a physician’s hand. Signaling a new era in pain diagnosis where the idea of chronic muscle pain will be virtually nonexistent. Veterinary medicine is another potential market, but quantitative analysis is pending.

http://www.stevens.edu/entrepreneurship/ventures/SPOC.html